Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sensus Healthcare, Inc.SRTS · Entity 7142 | CHIEF TECHNOLOGY OFFICER | March 22, 2019 | March 26, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sensus Healthcare, Inc.
Report date March 22, 2019 · Filed March 26, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 931,007 |
Reported balance
After 2019-03-22 transaction · row 1
1 source rowRow 1 · 2019-03-22 · Sale · Disposed 173 · Balance 931,007 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in February 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in February 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 22, 2019 Filed Mar 26, 2019 17:35 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 173 | $7.50 | $1,297.50 |
DisclosureSEC source: 0001415889-19-000390 · form4-03262019_020318.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,007 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in February 2019. Read SEC document |
| September 11, 2018 Filed Sep 12, 2018 21:27 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 631 | $7.51 | $4,738.81 |
DisclosureSEC source: 0001415889-18-001374 · form4-09122018_060911.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,180 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.53. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 21:27 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 1,114 | $7.55 | $8,410.70 |
DisclosureSEC source: 0001415889-18-001374 · form4-09122018_060911.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,811 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.56. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 29, 2018 Filed Aug 30, 2018 16:19 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 193 | $7.50 | $1,447.50 |
DisclosureSEC source: 0001415889-18-001306 · form4-08302018_010803.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932,925 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 16:19 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 699 | $7.50 | $5,242.50 |
DisclosureSEC source: 0001415889-18-001306 · form4-08302018_010803.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,118 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 16:30 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 1,682 | $7.50 | $12,615.00 |
DisclosureSEC source: 0001415889-18-001256 · form4-08102018_010822.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,817 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 16:30 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,020 | $7.50 | $15,150.00 |
DisclosureSEC source: 0001415889-18-001256 · form4-08102018_010822.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,499 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 15:40 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 210 | $7.50 | $1,575.00 |
DisclosureSEC source: 0001415889-18-001217 · form4-08062018_120855.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,519 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 16:54 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 452 | $7.50 | $3,390.00 |
DisclosureSEC source: 0001415889-18-001053 · form4-06282018_010659.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,729 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| June 25, 2018 Filed Jun 25, 2018 19:18 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 6,530 | $7.52 | $49,105.60 |
DisclosureSEC source: 0001415889-18-001021 · form4-06252018_040658.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 938,181 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 19:18 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,919 | $7.52 | $21,950.88 |
DisclosureSEC source: 0001415889-18-001021 · form4-06252018_040658.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 944,711 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.60. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 20, 2018 Filed Jun 20, 2018 18:29 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 4,767 | $7.52 | $35,847.84 |
DisclosureSEC source: 0001415889-18-000980 · form4-06202018_030600.xml · nonDerivative · entry 3 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947,630 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F6 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.65. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 18:29 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,626 | $7.57 | $19,878.82 |
DisclosureSEC source: 0001415889-18-000980 · form4-06202018_030600.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952,397 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.64. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 18:29 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 5,626 | $7.52 | $42,307.52 |
DisclosureSEC source: 0001415889-18-000980 · form4-06202018_030600.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 955,023 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 12:37 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 4,183 | $6.00 | $25,098.00 |
DisclosureSEC source: 0001615774-17-006044 · s107934_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 960,649 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.01. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 13, 2017 Filed Sep 19, 2017 14:03 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,114 | $6.00 | $12,684.00 |
DisclosureSEC source: 0001615774-17-005189 · s107548_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 14:50 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 1,561 | $6.00 | $9,366.00 |
DisclosureSEC source: 0001615774-17-005050 · s107487_form4.xml · nonDerivative · entry 3 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,946 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 08, 2017 Filed Sep 13, 2017 14:50 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 3,002 | $6.00 | $18,012.00 |
DisclosureSEC source: 0001615774-17-005050 · s107487_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,507 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 07, 2017 Filed Sep 13, 2017 14:50 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,771 | $6.00 | $16,626.00 |
DisclosureSEC source: 0001615774-17-005050 · s107487_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 971,509 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 19:36 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,250 | $6.00 | $13,500.00 |
DisclosureSEC source: 0001615774-17-004954 · s107421_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974,280 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 19:36 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 5,762 | $6.00 | $34,572.00 |
DisclosureSEC source: 0001615774-17-004954 · s107421_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,530 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.05. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 15:36 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 1,291 | $6.00 | $7,746.00 |
DisclosureSEC source: 0001615774-17-004832 · s107374_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 982,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 15:36 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 4,501 | $6.00 | $27,006.00 |
DisclosureSEC source: 0001615774-17-004832 · s107374_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 983,583 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.02. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 14:46 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,761 | $6.00 | $16,566.00 |
DisclosureSEC source: 0001615774-17-004747 · s107339_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988,084 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 14:46 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,617 | $6.00 | $15,702.00 |
DisclosureSEC source: 0001615774-17-004747 · s107339_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,845 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 18:31 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 123 | $6.00 | $738.00 |
DisclosureSEC source: 0001615774-16-008728 · s104872_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,463 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 18:31 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 64 | $6.00 | $384.00 |
DisclosureSEC source: 0001615774-16-008728 · s104872_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,586 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 18:01 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 382 | $6.00 | $2,292.00 |
DisclosureSEC source: 0001615774-16-008661 · s104831_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,650 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 18:01 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 297 | $6.00 | $1,782.00 |
DisclosureSEC source: 0001615774-16-008661 · s104831_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 994,032 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.